Grant winners

November 29, 2012

ARTS AND HUMANITIES RESEARCH COUNCIL

Follow-on Fund

Comparative approaches to Islam, security and television news: implications for policymakers and the media

  • Award winner: Fearghal McGarry
  • Institution: Queen's University Belfast
  • Value: £104,312

Documentary film, public history and education in Northern Ireland

Reconnecting with Gaelic Scotland's community traditions: the legacy of Calum Iain Maclean's collecting

Exploring outreach through medieval seals

Compositions for cochlear implantees follow-on project

ADVERTISEMENT

Enhancing choreographic objects (EChO)

BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL, CASE/COLORCON LTD

Investigation of the biological response to pharmaceutical excipients during drug absorption

ADVERTISEMENT

British Safety Council

Design a psychometric assessment tool to measure propensity for unsafe/risky behaviour at work

THE WATERLOO FOUNDATION

Dissecting the biological risk factors in developmental dyslexia

LEVERHULME TRUST

Research Project Grants

Humanities

  • Award winner: Peter Flugel
  • Institution: Soas, University of London
  • Value: £245,160

Johannes Klatt's Jaina-Onomasticon

The rhetoric of empire: managing imperial conflict between Britain and France

IN DETAIL

National Institute for Health Research Health Technology Assessment programme

ADVERTISEMENT
  • Award winner Jayant S. Vaidya
  • Institution University College London
  • Value £1,420,386

TARGIT-B: an international randomised controlled trial to compare targeted intra-operative radiotherapy boost with conventional external beam radiotherapy boost after lumpectomy for breast cancer in women with a high risk of local recurrence

This new technique delivers radiotherapy to the tissues at highest risk of recurrence - the tumour bed - at the time of surgery in a single session. Long-term analysis of the first 300 patients treated with this technique found a remarkably low recurrence rate. TARGIT boost will be compared with conventional boost to test its superiority, with the primary outcome local recurrence of cancer at five years.

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Register
Please Login or Register to read this article.

Sponsored

ADVERTISEMENT